Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
European Journal of Medicinal Chemistry
|
December 31, 2023
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability
Lisa Giannessi, Maria Giovanna Lupo, Ilaria Rossi, et al.
Journal of Clinical Lipidology
|
October 2, 2013
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients
Guido Franceschini, Elda Favari, Laura Calabresi, et al.
Alzheimer'S Research & Therapy
|
May 20, 2023
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease
Marta Turri, Elisa Conti, Chiara Pavanello, et al.
Journal of Alzheimer'S Disease : JAD
|
September 24, 2016
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease
Francesca Zimetti, Paolo Caffarra, Nicoletta Ronda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism
Nicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
Circulation. Cardiovascular Genetics
|
November 9, 2011
Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3
Livia Pisciotta, Elda Favari, Lucia Magnolo, et al.
Frontiers in Molecular Biosciences
|
August 5, 2022
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation
Marcella Palumbo, Antonina Giammanco, Francesco Purrello, et al.
Journal of Alzheimer'S Disease : JAD
|
November 5, 2024
Influence of <i>APOE4</i> genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum
Bianca Papotti, Marcella Palumbo, Maria Pia Adorni, et al.
Brain, Behavior, and Immunity
|
November 15, 2023
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice
Antonietta Vilella, Martina Bodria, Bianca Papotti, et al.
Nature Communications
|
November 1, 2023
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity
Amr Khalifa, Ana Guijarro, Silvia Ravera, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
European Journal of Medicinal Chemistry
|
December 31, 2023
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability
Lisa Giannessi, Maria Giovanna Lupo, Ilaria Rossi, et al.
Journal of Clinical Lipidology
|
October 2, 2013
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients
Guido Franceschini, Elda Favari, Laura Calabresi, et al.
Alzheimer'S Research & Therapy
|
May 20, 2023
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease
Marta Turri, Elisa Conti, Chiara Pavanello, et al.
Journal of Alzheimer'S Disease : JAD
|
September 24, 2016
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease
Francesca Zimetti, Paolo Caffarra, Nicoletta Ronda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism
Nicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
Circulation. Cardiovascular Genetics
|
November 9, 2011
Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3
Livia Pisciotta, Elda Favari, Lucia Magnolo, et al.
Frontiers in Molecular Biosciences
|
August 5, 2022
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation
Marcella Palumbo, Antonina Giammanco, Francesco Purrello, et al.
Journal of Alzheimer'S Disease : JAD
|
November 5, 2024
Influence of <i>APOE4</i> genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum
Bianca Papotti, Marcella Palumbo, Maria Pia Adorni, et al.
Brain, Behavior, and Immunity
|
November 15, 2023
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice
Antonietta Vilella, Martina Bodria, Bianca Papotti, et al.
Nature Communications
|
November 1, 2023
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity
Amr Khalifa, Ana Guijarro, Silvia Ravera, et al.
Page
of 8